CEO & Co-founder
Microbiologist with 7 years in pharma R&D at a Brisbane-based contract research organization, specializing in vaccine adjuvants and immunology. Completed his PhD at UQ in Molecular Biology and developed strong IP in mucosal immunity. Transitioning that research into a biotech venture focused on next-generation vaccine platforms for emerging infectious diseases.